Target Name: MIR642A
NCBI ID: G693227
Review Report on MIR642A Target / Biomarker Content of Review Report on MIR642A Target / Biomarker
MIR642A
Other Name(s): MIR642 | hsa-mir-642a | hsa-miR-642a-5p | microRNA 642a | hsa-miR-642a-3p | MIRN642 | mir-642a | MicroRNA 642a | hsa-mir-642

MIR642A: A Potential Drug Target and Biomarker for Chronic Pain

Introduction

Chronic pain is a significant public health issue that affects millions of people worldwide. The persistent nature of pain can have a significant impact on an individual's quality of life, and its associated economic burden is substantial. The development of new treatments for chronic pain is crucial for improving the lives of patients. One potential drug target and biomarker that has garnered significant interest in recent years is MIR642A.

MIR642A: Structure and Function

MIR642A is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for chronic pain. It is located in the gene IRR2B, which encodes the interleukin-1尾 (IL-1尾) receptor. IL-1尾 is a cytokine that plays a crucial role in the regulation of pain perception and inflammation.

MIR642A is a 24.8-kb long RNA molecule that contains 19 unique exons. It has a calculated folding structure of 6.9 ns, with a calculated transmembrane spacing of 4.5 ns. MIR642A has a single extracellular domain that consists of a 尾-sheet and a 尾 -hint. The 尾-sheet is composed of 12 amino acids and is responsible for the stability and stability of MIR642A.

MIR642A has been shown to play a role in the regulation of pain perception and inflammation. Several studies have demonstrated that MIR642A is involved in the regulation of pain perception, inflammation, and cellular stress. For instance, MIR642A has been shown to be involved in the regulation of pain sensitivity in animal models of chronic pain.

MIR642A has also been shown to play a role in the regulation of inflammation. Chronic pain is often associated with inflammation in the body, and MIR642A has been shown to be involved in the regulation of inflammation in response to pain. For instance, MIR642A has been shown to be involved in the regulation of inflammation in response to dental procedures, which can cause chronic pain.

MIR642A has also been shown to play a role in the regulation of cellular stress. Chronic pain is often associated with cellular stress in the body, and MIR642A has been shown to be involved in the regulation of cellular stress in response to pain. For instance, MIR642A has been shown to be involved in the regulation of cellular stress in response to exercise, which can cause chronic pain.

MIR642A as a Potential Drug Target

MIR642A has been shown to be involved in the regulation of pain perception, inflammation, and cellular stress, making it a potential drug target for chronic pain. Drugs that target MIR642A have the potential to treat chronic pain by modulating its activity.

One approach to targeting MIR642A is to use small molecules that can modulate its activity. Small molecules that have been shown to modulate MIR642A activity include inhibitors of nuclear export (NEX), inhibitors of protein-protein interactions (PPIs), and modulators of the activity of MIR642A itself.

Another approach to targeting MIR642A is to use antibodies that can bind to it. Antibodies that have been shown to bind to MIR642A include monoclonal antibodies (MAbs), bispecific antibodies (BSAs), and polyvalent antibodies.

MIR642A as a Biomarker

MIR642A can also be used as a biomarker for chronic pain. The level of MIR642A in the body can be measured using techniques such as qRT-PCR, western blotting, and mass spectrometry. By measuring the level of MIR642A in the body, researchers can determine its levels of expression and determine whether it is being modulated by drugs or other factors.

MIR642A has been shown to be involved in the regulation of pain perception and inflammation, making it a potential biomarker for chronic pain. The level of MIR642A in the body can be used to

Protein Name: MicroRNA 642a

The "MIR642A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR642A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR642B | MIR643 | MIR644A | MIR645 | MIR646 | MIR646HG | MIR647 | MIR648 | MIR649 | MIR6499 | MIR650 | MIR6500 | MIR6501 | MIR6502 | MIR6503 | MIR6504 | MIR6505 | MIR6506 | MIR6507 | MIR6508 | MIR6509 | MIR651 | MIR6510 | MIR6511A1 | MIR6511A2 | MIR6511A3 | MIR6511A4 | MIR6511B1 | MIR6511B2 | MIR6512 | MIR6513 | MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760